Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-04-004981
Filing Date
2004-04-22
Accepted
2004-04-22 16:58:47
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y96210e10vk.txt 10-K 448808
3 CODE OF ETHICS y96210exv14.txt EX-14 5485
4 CONSENT OF GRANT THORNTON LLP y96210exv23w1.txt EX-23.1 732
5 CERTIFICATION OF CEO y96210exv31w1.txt EX-31.1 3480
6 CERTIFICATION OF CFO y96210exv31w2.txt EX-31.2 3517
7 906 CERTIFICATION OF CEO y96210exv32w1.txt EX-32.1 1369
8 906 CERTIFICATION OF CFO y96210exv32w2.txt EX-32.2 1421
  Complete submission text file 0000950123-04-004981.txt   467048
Mailing Address 616 NORTH COURT . PALATINE IL 60067
Business Address 16235 STATE ROAD 17 CULVER IN 46511 847-705-7709
HALSEY DRUG CO INC/NEW (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 04748693
SIC: 2834 Pharmaceutical Preparations